Update on the therapeutic potential of PDE4 inhibitors

Expert Opinion on Investigational Drugs - Tập 11 Số 1 - Trang 1-13 - 2002
John G. Montana1,2, Hazel J. Dyke1,2
1Celltech R&D Ltd, Granta Park, Great Abington, Cambridge CB1 6GS, UK Tel: 01223-420430
2Fax: 01223-420440

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.1146/annurev.bi.48.070179.004423

BEAVO JA, 1995, Physiol. Rev, 75, 725, 10.1152/physrev.1995.75.4.725

10.1210/edrv-16-3-370

10.1006/abbi.1995.1429

10.1016/S0079-6603(00)65001-8

10.1517/13543776.10.9.1415

10.1164/ajrccm.157.2.9708012

10.1016/S0162-3109(00)00185-5

10.1517/13543784.8.9.1301

MARTIN TJ, 2001, 'drugs, 4, 312

10.1016/S0065-7743(08)61075-1

10.1016/S0223-5234(00)00179-3

10.1016/S0006-2952(98)00331-1

BARNETTE MS, 1999, Frog. Drug Res., 53, 193, 10.1007/978-3-0348-8735-9_5

10.1097/00063198-200003000-00014

10.1517/14728214.5.3.309

SPINA D, 2000, Cun: Op. Invest. Drugs, 1, 204

TOWARD TJ, 2001, j Pharmacol Exp. Ther, 298, 298

HATZELMANN A, 2000, j Pharmacol Exp. Ther, 297, 267

BUNDSCHUH DS, 2001, I Pharmacol Exp. Ther, 297, 280

10.1016/S0960-894X(99)00573-9

AOKI M, 2000, I Pharmacol Exp. Ther., 295, 255

AOKI M, 2001, Pharmacol Exp Ther, 297, 165

10.1016/S0960-894X(98)00583-6

FERRER P, 1997, Am. Respic Grit. Care. Med., 155, A660

10.1592/phco.21.7.653.34569

BROWN WM, 1999, Curr. Opiri. Anti-Infiamm. Immunomod. Invest. Drugs, 1, 39

10.1016/S0140-6736(01)05481-2

COMPTON C, 2000, Am. j. Respir. Grit. Care Med., 161, A505

10.1164/ajrccm.161.1.9806026

New drugs in R, 1998, Pharma Japan, 1609

Kyowa Hakko Kogyo, 1762, Pharma Japan, 2001, 17

10.1016/S0016-5085(98)84329-1

VIDELA S, 1998, Gastroenterology, 114, A1110

HARTMAN G, 2000, Pharmacol. Exp. Ther., 292, 22

10.1016/S0002-9440(10)65087-0

10.1517/13543776.8.5.531

GORR G, 2000, Arch. Pharmacol., 361, P89

SOUNESS JE, 1998, 'drugs, 1, 541

10.1016/S0014-2999(00)00330-7

10.1016/S0192-0561(99)00046-6

SCHAEFER CJ, 2001, FASEB, 15, A1212

10.1016/S0968-0896(99)00038-3

10.1016/S0960-894X(98)00572-1

10.1016/S0165-5728(00)00265-4

WAKI Y, 1999, fpri. j Pharmacol, 79, 477

10.1358/dnp.1999.12.9.863634

10.1016/S8756-3282(00)00395-1

10.1046/j.1523-1755.1999.00233.x

10.1159/000045539

THOMAS NJ, 2001, Pharmacol Exp. Ther, 296, 168

10.1191/096120301675275538

10.1016/S0893-133X(00)00108-1

BARDOU M, 2001, Therapie, 56, 213